BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• 

  FDA

  Better Late Than Never: Novartis, Momenta Win FDA Approval for Delayed MS Drug

  Teva and Mylan are looking over their shoulders this morning after the FDA gave Novartis and Momenta the green light for their Copaxone copycat drug.

  February 13, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  AI Biotech, BioXcel Therapeutics, Files for $69M IPO

  The Branford, CT-based company was founded in 2017 and plans to list on the Nasdaq under the symbol BTAI.

  February 13, 2018

   · 

  1 min read
• 

  Pharm Country

  Philly Life Sciences-Focused VC Firm, 1315 Capital, Nabs $300M+ for Second Fund

  1315 Capital focuses on early to mid-stage investments primarily for pharma and medtech companies.

  February 13, 2018

   · 

  1 min read
• 

  Drug Development

  “An Unrelenting Disaster Zone”: Merck’s Alzheimer’s Drug Fails in Phase III

  Alzheimer’s drug development took another hit.

  February 13, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  It’s Confirmed: Celgene’s Former CEO and Chairman is Making a Run for the Senate

  Bob Hugin announced his campaign on Monday in an email.

  February 13, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Charles River Slams Down $800M Cash for Global CRO

  The acquisition will strengthen Charles River’s position as a global early-stage CRO, expanding its client base and service portfolio.

  February 13, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Purdue Pharma Cuts More Than Half of U.S. Sales Staff Amid Opioid Crisis

  That announcement is a big change in the way Purdue has aggressively marketed OxyContin in the past.

  February 13, 2018

   · 

  2 min read

   · 

  Alex Keown
• Business

  Boehringer Ingelheim Demonstrates Their Commitment to Site Relationships by Joining SCRS’ Global Impact Partner Program

  Becoming a GIP demonstrates the company’s commitment to clinical research sites and their desire to develop a deeper understanding of the needs of sites, and contribute to the development and implementation of solutions.

  February 13, 2018

   · 

  2 min read
• 

  Business

  Not All of Alexion’s Top Execs Are Moving to Boston

  Moriarty and Wagner will not be making the move to Boston and will be leaving the company at the end of this month.

  February 13, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Pharm Country

  Walgreens Makes a Takeover Play for Drug Distributor AmerisourceBergen

  AmerisourceBergen is one of the biggest drug distributors in the U.S.

  February 13, 2018

   · 

  1 min read